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Chromosomal rearrangements, including transloca-
tions, require formation and joining of DNA double
strand breaks (DSBs). These events disrupt the in-
tegrity of the genome and are frequently involved in
producing leukemias, lymphomas and sarcomas.
Despite the importance of these events, current un-
derstanding of their genesis is limited. To examine
the origins of chromosomal rearrangements we de-
velopedTranslocationCaptureSequencing (TC-Seq),
a method to document chromosomal rearrange-
ments genome-wide, in primary cells. We examined
over 180,000 rearrangements obtained from 400 mil-
lion B lymphocytes, revealing that proximity between
DSBs, transcriptional activity and chromosome terri-
tories are key determinants of genome rearrange-
ment. Specifically, rearrangements tend to occur in
cis and to transcribed genes. Finally, we find that acti-
vation-induced cytidine deaminase (AID) induces the
rearrangement of many genes found as translocation
partners in mature B cell lymphoma.
INTRODUCTION
Lymphomas, leukemias, and solid tumors frequently carry gross
genomic rearrangements, including chromosomal transloca-
tions (Kuppers, 2005; Nussenzweig and Nussenzweig, 2010;
Tsai and Lieber, 2010; Tsai et al., 2008; Zhang et al., 2010).
Recurrent chromosomal translocations are key pathogenic
events in hematopoietic tumors and sarcomas; they may juxta-
pose proto-oncogenes to constitutively active promoters, deletetumor suppressors, or produce chimeric oncogenes (Rabbitts,
2009). For example, the c-myc/IgH translocation, a hallmark of
human Burkitt’s lymphoma andmouse plasmacytomas, deregu-
lates the expression of c-myc by bringing it under the control of
Immunoglobulin (Ig) gene transcriptional regulatory elements
(Gostissa et al., 2009; Kuppers, 2005; Potter, 2003). Alterna-
tively, in chronic myeloid leukemia, the Bcr/Abl translocation
fuses two disparate coding sequences to produce a novel,
constitutively active tyrosine kinase (Goldman and Melo, 2003;
Wong and Witte, 2004).
Chromosome translocation requires formation and joining of
paired DNA double strand breaks (DSBs), a process that may
be limited in part by the proximity of two breaks in the nucleus
(Nussenzweig and Nussenzweig, 2010; Zhang et al., 2010). B
lymphocytes are particularly prone to translocation-induced
malignancy, andmature B cell lymphomas are themost common
lymphoid cancer (Kuppers, 2005). This enhanced susceptibility
appears to be the direct consequence of activation-induced
cytidine deaminase (AID) expression in activated B cells (Nus-
senzweig and Nussenzweig, 2010). AID normally diversifies anti-
body genes by initiating Ig class switch recombination (CSR) and
somatic hypermutation (SHM) (Muramatsu et al., 2000; Revy
et al., 2000). It does so by deaminating cytosine residues in
single-stranded DNA (ssDNA) exposed by stalled RNA poly-
merase II during transcription (Chaudhuri and Alt, 2004; Pavri
et al., 2010; Storb et al., 2007). The resulting U:G mismatches
are then processed by one of several repair pathways to yield
mutations or DSBs, which are obligate intermediates in CSR,
but may also serve as substrates for translocation (Di Noia and
Neuberger, 2007; Honjo, 2002; Peled et al., 2008; Stavnezer
et al., 2008). Although AID has a strong preference for targeting
Ig genes, it also mutates a large number of non-Ig loci, including
Bcl6, Pax5, miR142, Pim1, and c-myc (Gordon et al., 2003; Liu
et al., 2008; Pasqualucci et al., 2001; Pavri et al., 2010; RobbianiCell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc. 95
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Figure 1. TC-Seq Schematic
IgHI or MycI primary B cells are infected with retroviruses
encoding I-SceI with or without AID. Genomic DNA is
fragmented, blunted, A-tailed, ligated to T-tailed asym-
metric linkers and native loci are eliminated by I-SceI
digestion. Rearrangements are amplified by semi-nested
ligation-mediated PCR followed by linker cleavage and
paired-end deep sequencing.et al., 2009; Shen et al., 1998; Yamane et al., 2011). While non-Ig
gene mutation frequencies are low, it has been estimated that
AID mutates as many as 25% of all genes expressed in germinal
center B cells (Liu et al., 2008).
The full spectrum of potential AID targets was revealed by
AID-chromatin immunoprecipitation studies, which showed AID
occupancy at more than 5000 gene promoters bearing stalled
RNA polymerase II (Yamane et al., 2011). AID is targeted to these
genes through its interactionwith Spt5, anRNApolymerase stall-
ing factor (Pavri et al., 2010). Consistent with its genome-wide
distribution, mice that overexpress AID exhibit chromosomal
instability and develop translocation-associated lymphomas
(Okazaki et al., 2003; Robbiani et al., 2009). Yet, c-myc is the
only gene conclusively shown to translocate as a result of AID-
induced DSBs (Ramiro et al., 2007; Robbiani et al., 2008). It has
beenestimated that up to5%of activatedprimaryB lymphocytes
carry IgH fusions to unidentified partners which may or may not
be selected during transformation (Franco et al., 2006; Jankovic
et al., 2010; Ramiro et al., 2006; Robbiani et al., 2009;Wang et al.,
2009; Yan et al., 2007). Additionally, recent deep-sequencing
studies have revealed hundreds of genomic rearrangements
within human cancers and documented their propensity to
involve genes (Campbell et al., 2008; Pleasance et al., 2010a;
Pleasance et al., 2010b; Stephens et al., 2009) However, the
role of selection or other physiologic constraints in the genesis
of these events is unclear because methods for mapping chro-
mosomal translocations in primary cells do not yet exist.
Here, we describe a novel, genome-wide strategy to docu-
ment primary chromosomal rearrangements. We provide insight
into the effects of genomic position and transcription on the
genesis of chromosomal rearrangements and DSB resolution.
Our data also reveal the extent of recurrent AID-mediated trans-
locations in activated B cells.
RESULTS
Translocation Capture Sequencing
To discover the extent and nature of chromosomal rearrange-
ments in activated B lymphocytes we developed an assay to
capture and sequence rearranged genomic DNA (TC-Seq). In
this system, DSBs are induced at the c-myc (chromosome 15)
or IgH (chromosome 12) loci, which were engineered to harbor
the I-SceI meganuclease target sequence (Robbiani et al.,
2008). c-mycI-SceI/I-SceI or IgHI-SceI/I-SceI (hereafter referred to as
MycI and IgHI) B cells were stimulated and infected with a
retrovirus expressing I-SceI, in the presence or absence of
AID. Rearrangements to I-SceI sites were recovered by semi-96 Cell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc.nested ligation-mediated PCR from genomic DNA that had
been fragmented, A-tailed (to prevent intramolecular ligation)
and ligated to asymmetric DNA linkers (Figure 1). Site-specific
primers were placed at least 150 bp from the I-SceI site allowing
for the capture of rearrangements involving moderate end-
processing. PCR products were submitted for high-throughput
paired-end sequencing and reads were aligned to the mouse
genome. Identical reads were clustered as single events. Since
sonication generates unique linker ligation points in each cell,
this method allows for the study of independent events without
sequencing through rearrangement breakpoints.
AID-Independent Translocations
In the absence of AID, DSBs arise as by-products of normal
cellular metabolism including transcription and DNA replication
(Branzei and Foiani, 2010). Consistent with a global distribution
of DSBs, we mapped 28,548 unique rearrangements between
the I-SceI site and every chromosome in MycIAID/ B cells
(100 million cells assayed, Figure 2A). To determine whether
there is a genome-wide bias for rearrangement, these events
were characterized based on location, transcription and histone
modification of the locus.
We found a marked enrichment of intrachromosomal rear-
rangements on chromosome 15, with approximately 125 events
per mappable megabase (11,066 rearrangements), or 40% of
all events (Figure 2B). Translocations between MycI and other
chromosomes were evenly distributed throughout the genome
(Figure 2B and Table S1). Notably, 86.7% (9591 of 11,066) of all
intrachromosomal rearrangements were localized within a 350
kb domain surrounding the I-SceI site (from 50 kb to +300 kb;
Figure 2C). This is consistent with the observation that 92% of
intrachromosomal rearrangements in the breast cancer genome
involve aberrant joining of DSBs within 2 Mb of each other
(Stephenset al., 2009), and that 87%ofRAG-mediated intrachro-
mosomal rearrangements in Abl-transformed pre-B cells lie
within 200 kb of a recombination substrate (Mahowald et al.,
2009). The asymmetrical distribution of events in the direction
of c-myc transcription and the adjacent Pvt1 gene is also consis-
tent with the idea that gene expression facilitates rearrangement
(Thomas and Rothstein, 1989). I-SceI-proximal events may be
the result of either resection and rejoining of I-SceI breaks,
bona fide rearrangements between I-SceI and random DSBs,
or a combination of DNA end resection and balanced transloca-
tions. Regardless of the precise molecular mechanism, the
abundance of these events reveals a strong preference for
DSBs to be resolved by ligation to a proximal sequence, a DNA
repair strategy that may minimize gross genomic alterations.
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Figure 2. Rearrangements to a DSB Site Documented by TC-Seq
(A) Genome-wide view of rearrangements to MycI in AID/ B cells.
(B) Rearrangements per mappable megabase to each chromosome in MycIAID/ B cells.
(C) Profile of rearrangements around the I-SceI site in 5 kb intervals.Recent cancer genome sequencing experiments uncovered
amodest but highly significant preference for cancer-associated
rearrangements to occur in genes, which compose only 41% of
the human genome. For example, in 24 sequenced breast
cancer genomes, 50% of all rearrangements involved genes
(Stephens et al., 2009). Whether this bias resulted from selection
or some inherent feature of DSB formation and repair specific
to cancer cells could not be determined. To ascertain whether
a similar bias is seen in primary cells in short term cultures,
AID-independent rearrangements in MycIAID/ B lymphocytes
(excluding 1Mb of DNA around the I-SceI site) were classified as
genic or intergenic. Consistent with the human tumor studies,
51% (9677 of 19,246) of the events were associated with genes
(Figure 3A). Because only 40% of the mouse genome is genic,
this represents a small (1.25-fold) but significant difference
(permutation test p < 0.001) relative to intergenic regions. More-
over, the genic rearrangements were particularly enriched at
transcription start sites (Figure 3B).
Consistent with the preference for genic rearrangements, we
also observed a bias to transcribed genes. Fewer rearrange-
ments than expected occurred at silent (fe = 0.74, p < 0.001)
and trace (fe = 0.95, p < 0.001) transcribed genes, while more
than expected occurred at low (fe = 1.08 p < 0.001), medium
(fe = 1.13, p < 0.001), and highly (fe = 1.14, p < 0.001) transcribedgenes (Figure 3C and Figure S1). Additionally, rearrangements
were enriched in genes bearing PolII and activating histone
marks such as H3K4 trimethylation, H3 acetylation, and H3K36
trimethylation (p < 0.001, Figure 3D). Thus, there is a propensity
for a DSB to recombine with gene rich regions of the genome and
more specifically to transcription start sites of actively tran-
scribed genes.
AID-Mediated Lesions Captured by TC-Seq
Processing of AID-induced U:G mismatches can result in DSBs
in Ig and non-Ig genes such as c-myc (Robbiani et al., 2008). To
determine whether AID-mediated DSBs can be captured by TC-
Seq we examined the IgH and c-myc loci in B cells expressing
retrovirally encoded AID (IgHIAIDRV or MycIAIDRV). IgHI B cells
expressing both I-SceI and AID showed extensive AID-
dependent rearrangement between the I-SceI site and down-
stream switch (S) regions (Figure 4A). The frequency of rear-
rangements resembled the pattern of AID-mediated CSR in
LPS+IL-4 cultures (e.g., IgG1[IgG3>IgE), with 18,686mapping
to Sg1, 3,192 to Sg3, and 1433 to S 3(Table S2). Furthermore,
translocations between c-myc and IgH were entirely dependent
on AID (Figures 4B and 4C). In two biological replicate samples
totaling 100 million B cells, we observed 45 translocations from
IgHI to c-myc (the I-SceI DSB was in IgH), and 5963 from MycICell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc. 97
01.0
Unrearranged genes
Rearranged genes
0
1.0
Sil
en
t
Tra
ce Lo
w
Me
diu
m
Hig
h
TS
S
50
%
TT
S
0.005
0.001
Intergenic
B
C
A
AID-/- 9677 9569 50.3
26221 25101 51.1
AIDWT 5651 5723 49.7
AIDRV 9475 8026 53.9
Genic Intergenic % genic
P (permutation test) < 0.001
Total Captured
AIDRV
D
Rearrangements
for all
Transcription Group
R
el
at
iv
e 
Fr
eq
ue
nc
y
R
el
at
iv
e 
Fr
eq
ue
nc
y
MycI
IgHI
Fr
eq
ue
nc
y MycIAID-/-
H3
K4
me
3
H3
Ac Po
lII
H3
K3
6m
e3
MycIAID-/-MycIAID-/-
Figure 3. Rearrangements to MycI Occur Near the
TSSs of Actively Transcribed Genes
(A) Rearrangements, excluding the 1 Mb around I-SceI,
were categorized as genic or intergenic.
(B) Composite density profile of genomic rearrangements
from MycI to genes (red line) and intergenic regions (blue
line). TSS = transcription start site, TTS = transcription
termination site.
(C) Relative frequency (fe) of rearrangements in genes that
are either silent or display trace, low,medium or high levels
of transcription in activated B cells as determined by
RNA-Seq (Figure S1). Dashed line indicates the expected
rearrangement frequency based on a random model. p <
0.001 for all (permutation test).
(D) Relative frequency of rearrangements in PolII- and
activating histone mark-associated gene groups (Yamane
et al., 2011). Dashed line indicates expected frequency
based on a random model. p < 0.001 for all samples
(permutation test).
Also see Figure S1.to IgH (the I-SceI DSBwas in c-myc) (Table S2). Additionally, TC-
Seq tags mapping to c-myc from IgHI correlate well with c-myc/
IgH translocation breakpoints sequenced from primary B cells
(Figure 4C) (Robbiani et al., 2008). This suggests that TC-Seq
reads are an accurate proxy for breakpoints. Furthermore, the
data corroborate previous findings showing that AID induced
breaks at c-myc are rate limiting for c-myc/IgH translocations
(Robbiani et al., 2008) and suggest that AID-dependent IgH
breaks are two orders of magnitude more frequent than those
at c-myc. We conclude that TC-Seq captures rearrangements
and translocations between DSBs in IgHI or MycI and known
AID targets.
As was the case for AID deficient samples, MycIAIDRV and
IgHIAIDRV libraries were enriched in intrachromosomal rear-
rangements: 17% (10,633 of 63,772 total events) for MycI and
70% (36,019 of 51,312) for IgHI (Table S1 and Figures S2A
and S2B). The difference in enrichment between the two was
mostly the result of AID activity on chromosome 12, which
generated a large number of rearrangements to IgH variable
and constant domains (Figure 4A). Expression of AID did not
alter the distribution of events around MycI, with 72.5% (770798 Cell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc.of 10,633) mapping within 50 kb to 300 kb of
the break (Figure S2C). A notable exception
was an additional cluster of rearrangements
associated with Pvt1 exon 5 (Figure S2C). These
events coincided precisely with documented
chromosomal translocations isolated from AID
sufficient mouse plasmacytomas (Cory et al.,
1985; Huppi et al., 1990) and likely represent
an AID hot spot.
In agreement with the MycIAID/ samples,
translocations between IgHI or MycI and other
chromosomes were evenly distributed through-
out the genome, except for the MycI capture
sample, which displayed a marked bias for
chromosome 12 due to creation of DSBs at
the IgH locus by AID (Figure S2A). Similar to
MycIAID/ samples, rearrangements in both
cases were more likely to occur in regions that are genic, tran-
scriptionally active, recruiting PolII, and associated with acti-
vating histonemarks (Figure 3A and Figures 4D and 4E). Further-
more, intragenic rearrangements were enriched at transcription
start sites of genes (Figure S2D). In contrast to recent studies
that used Nbs1 as an indirect marker of AID mediated damage
(Staszewski et al., 2011), we found little or no difference in
rearrangements to genomic repeats in the presence of AID
(Table S3). Thus, AID does not dramatically alter the general
profile of rearrangements.
Next, we examined whether IgHI and MycI capture DSB
targets at similar rates. Indeed, in AID sufficient samples, total
translocations from a given chromosome to IgHI or MycI
occurred at roughly similar frequencies (Figure 4F). This similarity
could be explained by the close physical proximity of IgH and
c-myc, as suggested by studies with EBV-transformed B lym-
phoblastoid cells (Roix et al., 2003). Alternatively, the correlation
in transchromosomal joining might represent random ligation
between I-SceI DSBs in IgH or c-myc and DSBs on other chro-
mosomes. We conclude that extra-chromosomal DSBs ligate
DSBs in IgHI and MycI at similar rates.
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Figure 4. Rearrangements to IgHI or MycI in Primary B Cells Expressing AID
(A and B) (A) Rearrangements per kb to I-SceI sites (indicated with an asterisk) in IgH or (B) c-myc in AID/ (top panel) or AIDRV cells (bottom panel). White boxes
in the schematics below each graph represent Ig switch domains while black boxes depict constant regions.
(C) Translocations per 100 bp from IgHI to c-myc in AID/ (top panel) or AIDRV cells (bottom panel). Green arrows indicate c-myc/IgH translocation breakpoints
sequenced from primary B cells (Robbiani et al., 2008).
(D) Relative frequency of rearrangements in transcription-level gene groups (Figure S1), dashed line indicates expected frequency based on a random model.
Asterisks highlight values with a p < 0.001 (permutation test).
(E) Relative frequency of rearrangements in PolII-associated or activating histone mark-associated gene groups (Yamane et al., 2011). Dashed line indicates the
expected frequency based on a random model. p < 0.001 for all samples (permutation test).
(F) Graph comparing the number of translocations per mappable megabase to each chromosome from IgHI (y axis) or MycI (x axis).
(G) Ratio of IgHI captured to MycI captured events in 500 kb bins moving away from the I-SceI capture site (both directions combined). Dotted line represents the
average transchromosomal joining rate computed on all chromosomes other than 12 or 15. Gray areas show 2 standard deviations around the mean.
Also see Figure S2.To examine the nature of the intrachromosomal rearrange-
ment bias we calculated the ratio of IgHI to MycI captured events
for each 500 kb segment of the genome and compared the
values for chromosome 12 and 15 to the transchromosomal
average (Figure 4G and Figure S2E). This analysis revealed
that DSBs are preferentially captured intrachromosomally and
this effect diminishes at a rate inversely proportional to the
distance from the I-SceI site (d-1.29) (Figure S2F). This effect
was most prominent locally but was evident at up to 50 Mb
away from the I-SceI break. We conclude that paired DSBs arepreferentially joined intrachromosomally and that the magnitude
of this effect decreases with increasing distance between the
two lesions.
Translocation Hot Spots
To determine whether there are hot spots for rearrangement, we
searched the B cell genome for local accumulations of reads in
AID deficient and sufficient samples. TC-Seq hot spots were
defined as a localized enrichment of rearrangements above
what is expected from a uniform genomic distribution. WeCell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc. 99
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Figure 5. AID-Dependent Rearrangement Hot
Spots
(A) Screenshots of translocations per 100 bp present at
Il4i1 and Pax5 genes in all samples.
(B) Overlap of AID-dependent hot-spot-bearing genes in
IgHIAIDRV and IgHIAIDWT experiments.
(C) Overlap of AID-dependent hot-spot-bearing genes in
IgHIAIDRV, MycIAID/ and MycIAIDRV experiments.
(D) Empirical cumulative distribution showing transcript
abundance in genes displaying (red) or lacking (black)
rearrangement hot spots. Filled-in gray slice represents
2000 highly transcribed unrearranged genes.
(E) Total rearrangements as a function of gene ex-
pression (RNA-Seq) (Yamane et al., 2011) in genes bearing
rearrangement hot spots.
Also see Figure S3.removed likely artifacts; namely hot spots containing >80% of
reads within DNA repeats, and those with footprints of <100 nt
(because translocations are amplified from randomly sonicated
DNA (Figure 1), deep-sequence tags associated with bona fide
rearrangements are unlikely to map within a small region).
We identified 34 hot spots captured by MycI in the absence of
AID (Table S4). There were 31 hot spots in 17 genes and three in
nongenic regions (Table S4). Seventeen of the hot spots were in
Pvt1, within 500 kb of the I-SceI site. In addition, two hot spots
occurred within 5 kb of cryptic I-SceI sites (each bearing one
mismatch to the 18-base pair recognition sequence). For
example, one such hot spot at chr15:16219195-16219312 con-
taining a 1-off I-SceI recognition sequence bore 8 rearrange-
ments (Figure S3). A genome-wide search for rearrangements
within 5 kb of cryptic I-SceI sites (83 within the mouse genome
with 1 or 2 mismatches to the canonical I-SceI recognition100 Cell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc.sequence) yielded 57 events, seven times
more than expected in a random distribution
model. When allowing up to 6 mismatches we
find a total of five out of 34 AID-independent
hot spots near putative cryptic I-SceI sites.
Although I-SceI has been used to generate
a unique DSB in gene targeting and DNA repair
experiments, our data suggest that DNA re-
cognition by I-SceI can be promiscuous in the
mouse genome, as demonstrated for other
yeast endonucleases (Argast et al., 1998).
In contrast to AID/, we found 157 AID-
dependent hot spots in 83 genes captured by
IgHIAIDRV and 60 hot spots in 37 genes by
MycIAIDRV in 100 million B cells. (Table S4).
80% of the hot spots captured by c-myc and
90% of those captured by IgH were within
genes. For example, we found robust AID-
dependent hot spots on Il4i1 and Pax5 (a recur-
ring IgH translocation partner in lymphoplasma-
cytoid lymphoma [Kuppers, 2005]) (Figure 5A
and Table S4). AID-dependent hot spots were
similar for IgHI B cells expressing wild-type
levels (WT) or retrovirally overexpressed (RV)
AID, however the number of events was de-creased in the former (Figures 5A and 5B and Table S4). There-
fore, translocations to AID targets occur in cells expressing
physiological levels of AID and hotspots are not dependent on
AID overexpression. We conclude that AID produces substrates
for translocations in a number of discreet sites throughout the
genome, and these sites are mainly in genes.
Genes containing AID-dependent hotspots overlapped
between IgHIAIDRV and MycIAIDRV samples (Figure 5C). Consis-
tent with the similar capture rates observed for transchromoso-
mal targets (Figure 4F), we found that 28 of the frequently trans-
located targets were shared (Table S5). In contrast, we found
a number of unique intrachromosomal AID-dependent hot spots.
For example, rearrangements to Inf2 on chromosome 12 (850
kb from IgHI) were only found by IgHI capture while rearrange-
ments near Pvt1 on chromosome 15 (up to 350 kb from MycI)
were only found by MycI capture (Table S5). Thus, there is
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Figure 6. Characterization of AID-Dependent Hot
Spots
(A) Composite density graph showing the distribution of
rearrangements in genes associated with AID-dependent
hotspots relative to the TSS.
(B) Spt5 and AID recruitment at genomic sites associated
with translocation hotspots (Pavri et al., 2010; Yamane
et al., 2011).
(C) Somatic hypermutation frequency versus number of
rearrangements in genes bearing AID-dependent trans-
location hotspots.
(D) Distribution of AID, Spt5. and translocations inRohema
and Hist1 genes.
Also see Figure S4.a bias toward recombination between I-SceI breaks and AID hot
spots within the same chromosome. Additionally, the finding that
some hot spots are only captured in cis indicates that TC-Seq
underestimates the number of AID mediated DSBs in the
genome and suggests that we have not reached saturation.
Combinedanalysisof the IgHI andMycI TC-Seqdatasetsshows
that AID-dependent hot spots are primarily found in transcribed
genes (Figure 5D). However, although nearly all of the translocated
genes are actively transcribed, there is no clear correlation
between transcript abundance and rearrangement frequency
(Figure 5E). Furthermore, 2000 highly transcribed genes are not
rearranged (Figure 5D, shaded area). Therefore, transcription is
necessary but not sufficient for AID targeting, and transcription
levels alone cannot account for AID-dependent DSBs.
AID-dependent hot spots are biased to the region around the
transcription start site (Figure 6A). This finding is consistent with
the accumulation of AID and Spt5 around the promoters of
stalled genes and the distribution of somatic hypermutation
(Pavri et al., 2010; Yamane et al., 2011). Indeed, AID-dependent
TC-Seq hot spots overlap with regions of AID (Figure S4A) and
Spt5 accumulation (Figures 6B and 6D). This correlation promp-
ted us to explore the relationship between AID activity and accu-
mulation of chromosomal translocations by measuring somatic
hypermutation at TC-Seq captured AID targets (Yamane et al.,
2011 and Table S6). We found a positive correlation (Spearman
coefficient = 0.84) between hypermutation and rearrangement
frequency (Figure 6C). All genes analyzed with a mutation rate
over 10x105 bear rearrangements, and all genes with AID-
dependent TC-Seq hot spots show mutations (Figure 6C). Rear-
rangements were only seen rarely in genes with lower rates of
mutation (Figure 6C). This suggests that the rate of hypermuta-
tion and the frequency of AID-induced DSBs are directly propor-
tional. We conclude that AID-dependent TC-Seq hot spots occur
on stalled genes that accumulate Spt5, AID, and high rates of
hypermutation.
Among AID-dependent hot spot containing genes we find
several that are translocated or deleted in mature B cellCell 147, 95–lymphoma. These include Pax5/IgH, Pim1/
Bcl6, Il21r/Bcl6, Gas5/Bcl6, and Ddx6/IgH
translocations and Junb and Socs1 deletions
in diffuse large B cell lymphoma, Birc3/Malt1
translocation in MALT lymphoma, Ccnd2/IgK
translocation and Bcl2l11 deletion in mantlecell lymphoma, Aff3/Bcl2 and Grhpr/Bcl6 translocations in
follicular lymphoma, mir142/c-myc translocation in B cell pro-
lymphocytic leukemia as well as c-myc/IgH and Pvt1/IgK trans-
locations in Burkitt’s lymphoma (Table 1). Interestingly, we find
that AID is capable of inducing DSBs in Fli1 (Table S4), which
is translocated to EWS in 90% of Ewing’s sarcomas, a malignant
tumor of uncertain origin (Riggi and Stamenkovic, 2007). We
conclude that in addition to mutating many genes, AID also initi-
ates DSBs in numerous non-Ig genes. These genes serve as
substrates for translocations associated with mature B cell
lymphoma, strongly implicating AID as a source of genomic
instability in these cancers.
DISCUSSION
To date, the study of chromosomal aberrations has been
primarily limited to events identified in tumors and tumor cell
lines. Although we have learned a great deal about the impor-
tance of genomic rearrangements in cancer, it has not been
possible to develop an understanding of the cellular and molec-
ular requirements that govern their genesis. To examine genomic
rearrangements in primary cells in short term cultures, we devel-
oped a technique to catalog these events by deep sequencing,
TC-seq. Our results and analysis reveal the importance of tran-
scription and physical proximity in recombinogenesis, and iden-
tifies hotspots for AID-mediated translocations in mature B cells.
Nuclear Proximity and Chromosomal Position
The existence of chromosome territories, regions in which indi-
vidual chromosomes segregate, has been long proposed
(Cremer and Cremer, 2001) and recently shown to be a key
feature of genome organization (Lieberman-Aiden et al., 2009).
Our analysis provides evidence that physical proximity and chro-
mosome territories are partial determinants for joining of specific
rearrangement partners. The effects of physical proximity are
most evident in the 350 kb region around the DSB. In the
absence of AID the plurality of rearrangements fall in this region.106, September 30, 2011 ª2011 Elsevier Inc. 101
Table 1. AID-Dependent Translocations in Human B Cell
Lymphoma
TC-Seq
Gene
Translocation in
Mature BCL
Mature
BCL Type Reference
Birc3 (Api2) t(11;18)(q21;q21) MALT (Rosebeck et al., 2011)
Il21r t(3;16)(q27;p11) DLBCL (Ueda et al., 2002)
Pax5 t(9;14)(p13;q32) DBLCL (Iida et al., 1999)
Pim1 t(3;6)(q27;p21.2) DLBCL (Yoshida et al., 1999)
Aff3 t(2;18)(q11.2;q21) FL (Impera et al., 2008)
Gas5 t(1;3)(q25;q27) DLBCL (Nakamura et al., 2008)
Ccnd2 t(2;12)(p12;p13) MCL (Gesk et al., 2006)
c-myc t(8;14)(q23;q32) BL (Kuppers, 2005)
Ddx6 (Rck) t(11;14)(q23;q32) DLBCL (Lu and Yunis, 1992)
Grhpr t(3;9)(q27;p11) FL (Akasaka et al., 2003)
Bcl2l11 Deleted MCL (Bea et al., 2009)
Socs1 Deleted DLBCL (Mottok et al., 2009)
Junb Deleted DLBCL (Mao et al., 2002)
mir142 t(8;17) B-PLL (Gauwerky et al., 1989)
Pvt1 t(2;8)(p11.2;q24.1) BL (Einerson et al., 2006)
IgH several several (Kuppers, 2005)
IgK several several (Kuppers, 2005)
IgL several several (Kuppers, 2005)
Genes bearing AID-dependent TC-Seq hotspots are shown with the
associated translocation or deletion observed in human mature B cell
lymphoma (BCL). BCL types are abbreviated as follows: MALT,
mucosa-associated lymphoid tissue lymphoma; DLBCL, diffuse large B
cell lymphoma; FL, follicular lymphoma; MCL, mantle cell lymphoma;
BL, Burkitt’s lymphoma; B-PLL, B cell prolymphocytic leukemia.This observation is consistent with the analysis of rearrange-
ments in the breast cancer genome and suggests that the abun-
dance of these events is independent of cancer specific selec-
tion (Stephens et al., 2009). Additionally, a preference for DSB
repair within 350 kb matches the range of gamma-H2AX
spreading from a DSB (Bothmer et al., 2011). This is consistent
with the idea that the DNA damage response facilitates proximal
rearrangement, a phenomenon most prominent at the IgH locus
during CSR.
Themagnitude of the effect of chromosome territories on rear-
rangement is far less prominent than proximal joining, but is
consistent with recent genome mapping data obtained by
high-throughput chromosome conformation capture (Hi-C) (Lie-
berman-Aiden et al., 2009). Intrachromosomal joining bias is
evident in the preferential joining of AID hotspots and nonhot-
spots on Chr12 and Chr15 with their respective I-SceI breaks.
When compared to transchromosomal joining, the bias to intra-
chromosomal rearrangements is evident even when DSBs are
separated by as much as 50 Mb. In mouse, the mean autosome
size is 130 Mb, so a 50 Mb preference for intrachromosomal
joining on either side of a DSB will encompass nearly the entire
average chromosome. We conclude that intrachromosomal
joining is preferred to transchromosomal joining.
Since this effect diminishes with distance, it is mediated by
proximity, a likely consequence of local chromosome packing
and nuclear chromosomal territories. A strong preference for102 Cell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc.proximal intrachromosomal rearrangement minimizes gross
genomic alterations. We propose that this may be an important
feature of DSB repair regulation that maintains genomic integrity.
Transcription
Transcription is associated with increased rates of DNA damage
and genome instability; these effects are likely mediated by
a number of different mechanisms (Gottipati and Helleday,
2009). Transcription may expose ssDNA, which is susceptible
to chemical or oxidative damage (Aguilera, 2002). Additionally,
head-on collision of the replication and transcription machinery
has been implicated in fork stalling and genomic instability
(Takeuchi et al., 2003). Consistent with these ideas, TC-Seq
reveals that transcription facilitates DNA rearrangement. In the
case of the c-myc locus, transcription increases the size of the
local area around a DSB that is available for recombination
from 50 kb to 300 kb. Moreover, I-SceI breaks rearrange pre-
dominantly to transcribed genes genome-wide andmore specif-
ically to the TSS. Thus, exposed ssDNA may serve as a primary
source of genomic instability. AID expression further reinforces
this phenomenon by creating U:G mismatches in ssDNA at sites
of PolII stalling downstream of the TSS (Pavri et al., 2010).
A bias for rearrangement between genic regions was also
reported in recent studies of the cancer genome, but the role
of transcription, transformation or selection in these events could
not be evaluated (Stephens et al., 2009). Our experiments de-
monstrate that transcribed genic regions are over-represented
in chromosomal rearrangements in primary cells in short-term
cultures. In addition to being more susceptible to damage, this
effect may be due to the increased physical proximity of tran-
scribed regions to each other in the nucleus (Lieberman-Aiden
et al., 2009). We speculate that this phenomenon may have
consequences for tumorigenesis. The rearrangement of proto-
oncogenes to transcribed regions may lead to their deregulation
or produce hybrid entities that alter cellular metabolism.
AID and Chromosome Translocation
AID initiates SHM, CSR, and chromosome translocation by
deaminating cytosine residues in ssDNA exposed by transcrip-
tion (Chaudhuri and Alt, 2004; Di Noia and Neuberger, 2007;
Nussenzweig and Nussenzweig, 2010; Peled et al., 2008; Stav-
nezer et al., 2008). AID targets the IgH locus and the TSSs of
stalled genes through direct interaction with Spt5, a PolII stalling
factor (Pavri et al., 2010), resulting in widespread somatic muta-
tions (Yamane et al., 2011). Additionally, AID has been shown to
initiate DSBs in non-Ig targets such as c-myc, and generates
diverse translocations and chromosome breaks (Robbiani
et al., 2008; Robbiani et al., 2009). However the precise relation-
ships between AID and Spt5 occupancy, mutation, and translo-
cations have not previously been investigated.
By capturing and sequencing chromosomal rearrangements,
a readout for aberrantly resolved DSBs, we have gained insight
into themechanisms bywhich AID targets DNA for chromosomal
rearrangement. First, we show that AID targets discreet sites in
the genome for DSB. These sites are predominantly genic and
actively transcribed. A recent study using Nbs1-ChIP as a surro-
gate for DNA damage suggested that AID targets repeat rich
sequences (Staszewski et al., 2011). In contrast, we find no
AID-dependent increase in rearrangements to repeats. More-
over, AID-dependent rearrangement hotspots predominantly
occur in genes, not in or near repeat regions that are not tran-
scribed. Hotspots that do fall in repeats (Figure S4B), are not
AID-dependent and do not suffer somatic hypermutation
(Table S6). While it is difficult to map short reads to repetitive
sequences, these data suggest that rearrangements to repeats
may be from AID-independent DSB.
While genes rearranged by AID are largely transcribed,
expression and PolII accumulation do not correlate directly
with rearrangement frequency suggesting that transcription is
necessary but not rate-limiting for rearrangement. Reflecting
the distribution of AID and its co-factor Spt5 in the genome (Pavri
et al., 2010; Yamane et al., 2011), AID-dependent rearrange-
ments occur mainly on transcription start sites of stalled genes
that carry high levels of the PolII stalling factor Spt5. In addition,
we find a strong and direct correlation between hypermutation
and rearrangements, suggesting that genes susceptible to AID
mediated recombinogenesis are a subset of the most highly
mutated genes in the genome. Consistent with this notion, we
show that Pax5, Il21r, Gas5, Ddx6, Birc3, Ccnd2, Aff3, Grhpr,
c-myc, Pvt1, Bcl2l11, Socs1, mir142, Junb, and Pim1, which
are translocated or deleted in mature B cell lymphomas (Table 1)
are among the more highly mutated AID targets and bear AID-
dependent translocation hotspots. Our experiments were per-
formed on in vitro stimulated B cells. Germinal center B cells
will have an alternate gene expression profile that might influ-
ence the number and position of AID target sites. We conclude
that in addition to hypermutation, AID is also a source of genomic
instability in mature B cell lymphomas.
Finally, we note that TC-seq can be adapted for use in other
cell types to study translocation biology in any tissue.EXPERIMENTAL PROCEDURES
B Cell Cultures, Infections, and Sorting
Resting B lymphocytes were isolated from mouse spleens by immunomag-
netic depletion with anti-CD43 MicroBeads (Miltenyi Biotech) and cultured at
0.5 3 106 cells/ml in RPMI supplemented with L-glutamine, sodium pyruvate,
antibiotic/antimycotic, HEPES, 50 mM 2-mercaptoethanol (all from GIBCO-
BRL), and 10% fetal calf serum (Hyclone). B cells were stimulated in the pres-
ence of 500 ng/ml RP105 (BD PharMingen), 25 mg/ml lipopolysaccharide (LPS)
(Sigma) and 5 ng/ml mouse recombinant IL-4 (Sigma). Retroviral supernatants
were prepared by cotransfection of BOSC23 cells with pCL-Eco and pMX-
IRES-GFP-derived plasmids encoding for I-SceI-mCherry or AID-GFP with
Fugene 6, 72 hr before infection. At 20 and 44 hr of lymphocyte culture, retro-
viral supernatants were added, and B cells were spinoculated at 1150 g for
1.5 hr in the presence of 10 mg/ml polybrene. For dual infection, separately
prepared retroviral supernatants were added simultaneously on both days.
After 4 hr at 37C, supernatants were replaced with LPS and IL-4 in supple-
mented RPMI. At 96 hr from the beginning of their culture, singly infected B
cells were collected and frozen in 10 million cell pellets at 80C. Dually in-
fected B cells were sorted for double positive cells with a FACSAria instrument
(Becton Dickson) then frozen down.
Translocation Capture Sequencing
Genomic DNA Library Preparation
53 10million B cell aliquots were lysed in Proteinase K buffer (100mMTris [pH
8], 0.2% SDS, 200 mM NaCl, 5 mM EDTA) and 50 ml of 20mg/ml Proteinase K.
Genomic DNA was extracted by phenol chloroform precipitation and frag-
mented by sonication (Bioruptor - Diagenode) to yield a 500–1350 bp distribu-tion of DNA fragments. DNAwas divided into (5ug) aliquots in 1.5mL eppendorf
tubes. Each experiment consisted of genomic DNA from 50 million B cells in
503 5 mg aliquots for a total of 250 mg of fragmented genomic DNA per exper-
iment. Subsequent reactions were performed individually on 5 mg aliquots.
DNA was blunted by End-It DNA Repair Kit (Epicenter), purified, then adeno-
sine-tailed by Klenow fragment 3 / 50 exo- (NEB) and purified. Fragments
were ligated to 200 pmol of annealed linkers (pLT + pLB) (Table S8A) and un-
rearranged loci were eliminated by I-SceI digestion. Reactions were purified
and pooled.
Rearrangement Amplification
Pooled linker-ligated DNA was divided into two equal parts for semi-nested
ligation-mediated PCR using either forward or reverse primers (to capture re-
arrangements to either side of the I-SceI break). All PCRs were performed
using the Phusion Polymerase system (NEB). DNA was divided into 1ug
aliquots and subjected to single-primer PCR with biotinylated pMycF1,
pMycR1, pIghF1 or pIghR1 [1x(98C-1min) 12x(98C-15s, 65C-30s, 72C-45s)
1x(72C-1min)] (Table S8A). Each reaction was spiked with pLinker and sub-
jected to additional cycles of PCR [1x(98C-1min) 35x(98C-15s, 65C-30s,
72C-45s) 1x(72C-5min)]. Forward and reverse PCR reactions were pooled
separately. Higher molecular weight products were isolated by agarose gel
electrophoresis and magnetic streptavidin bead purification. Semi-nested
PCR was performed on the magnetic beads with pMycF2, pMycR2, pIghF2,
or pIghR2 and pLinker (Table S8A) [1x(98C-1min) 35x(98C-10s, 65C-30s,
72C-40s) 1x(72C-5min)]. Higher molecular weight products were isolated by
agarose gel electrophoresis.
Paired-End Library Preparation
Linkers were removed by AscI digestion. Fragments were blunted by End-It
DNA Repair Kit (Epicenter), purified, adenosine-tailed and ligated to Illumina
paired-end adapters. Higher molecular weight products were isolated by
agarose gel electrophoresis and adaptor-ligated fragments were enriched
by 25 cycles of PCR with Illumina primers PE1.0 and PE2.0. Forward and
reverse libraries for the same sample were mixed in equimolar ratios and
sequenced by 36 3 36 or 54 3 54 paired end deep sequencing on an
Illumina GAII.
TC-Seq Computational Analysis
Read Alignment
Each end of the paired end sequences was matched against the relevant bait
primer plus genomic sequences allowing up to two mismatches with bowtie
(V 0.12.5; command line options: –v2). For read pairs longer than 2 3 36 nts,
10 nts were trimmed of the 30 end of each read. Each read pair with a single
match to one of the primers was then checked for a perfect match to the linker
on the second arm. If the linker was present, this arm was designated a target
arm, linker sequence was trimmed, and the remainder was aligned against the
mouse genome (NCBI 37/mm9) with bowtie allowing up to 2 mismatches and
requiring unique alignments in the best alignment stratum (command line
options: -v2 –all –best –strata -m1:). Exactly identical alignments (same posi-
tion, same strand) were combined into a single putative translocation event
and events supported by a single alignment were not considered in any anal-
yses. We also removed putative translocation events closer than 1 kb to their
respective bait. For hotspot analyses the exclusion limit was increased to 50
kb. Translocation positions were given as the position of the 50 end of the
read in the alignment. Data from technical and biological repeats were pooled
to increase saturation (Table S7).
Mapping of Translocation Hot Spots
A translocation hotspot was defined as a localized enrichment of translocation
events above what is expected from the null hypothesis of uniform distribution
of translocation events along the genome. To identify such hotspots, candi-
date regions were defined as locations containing consecutive translocations
with distances shorter than expected from the mappable size of the mm9
genome assembly (p < 0.01 each as determined by a negative binomial
test). For a candidate region to be called a hotspot it had to (1) have more
than 3 translocations and (2) have at least one read from each of the two sides
of the bait and (3) have at least 10% of the translocations come from each side
of the bait and (4) have a combined P value less than 109 given the number of
translocations and length of the region as determined by a negative binomial
test. Hotspots with a large degree (>80%) of overlap with repeat regions, smallCell 147, 95–106, September 30, 2011 ª2011 Elsevier Inc. 103
footprints (<100nt) or less than 10-fold enrichment over the AID/ control
were removed. Analyses of RNA-Seq, chromatin modifications, AID-, PolII-,
and Spt5-ChIP as well as the identification of cryptic I-SceI sites, TSSs, genic
and intergenic domains were carried out in R (http://www.R-project.org).
Hypermutation Analysis
CD43- splenocytes from IgkAID-Ung/ or Aicda/ mice were cultured at
0.1 3 106 cells/ml with LPS+IL-4, and 0.5 mg/ml of aCD180 (RP105) antibody
(RP/14, BD PharMingen). At 72 hr cells were diluted 1:4 and cultured for
another 48 hr. 50 ng of genomic DNA was amplified for 30 cycles with Phusion
DNA polymerase (New England Biolabs) and specific primers (Table S8B). For
nested PCR, two-20 cycle amplifications were performed with DMSO. The
amplicon was cloned using PCR Zero blunt (Invitrogen) and sequenced.
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